Mia's Feed
Medical News & Research

Research Suggests Common Cold May Offer Temporary Protection Against COVID-19

Research Suggests Common Cold May Offer Temporary Protection Against COVID-19

Share this article

New research reveals that recent infection with the common cold may offer temporary protection against COVID-19 by boosting the immune response, helping explain why children often experience milder symptoms.

2 min read

Recent research conducted by scientists at National Jewish Health indicates that experiencing a common cold, predominantly caused by rhinoviruses, may provide temporary immunity against SARS-CoV-2, the virus responsible for COVID-19. The study sheds light on potential reasons why children tend to have milder COVID-19 symptoms compared to adults and opens avenues for developing new preventive strategies.

Published in the Journal of Infectious Diseases, the study analyzed data from the nationwide HEROS project, which followed over 4,100 individuals across 1,394 households from May 2020 to February 2021. The findings revealed that individuals, especially children, who had a recent rhinovirus infection were significantly less likely to contract SARS-CoV-2 in subsequent weeks. This protective effect is believed to be linked to the body's antiviral defenses, notably the interferon response triggered by rhinoviruses, which temporarily 'primes' the immune system.

Senior author Max Seibold, Ph.D., emphasized that this immune boost from a common cold could give the body an early advantage in combating SARS-CoV-2. The research further found that children tend to have higher baseline levels of interferon-related genes, which play a crucial role in the immune response. This phenomenon, known as heterologous viral interference, had been observed with other respiratory viruses and is now being shown to potentially impact COVID-19 susceptibility.

Importantly, experts warn that this does not suggest people should aim to catch colds intentionally. Instead, understanding how viral infections influence immune responses could aid in developing new preventative measures, especially for vulnerable populations. The study's collaborative effort across 12 U.S. cities underscores the significance of this discovery in public health.

While the research provides promising insights, further studies are needed to explore how these immune mechanisms can be harnessed for broader protection. Overall, the findings contribute to explaining the lower severity and incidence of COVID-19 among children and suggest that recent viral exposures and immune differences play pivotal roles.

Source: https://medicalxpress.com/news/2025-08-common-cold-covid.html

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Gut Microbes as a Key to Enhancing Cancer Immunotherapy Response Through Exercise

New research uncovers how exercise reshapes the gut microbiome to produce compounds like formate, enhancing cancer immunotherapy response and improving patient outcomes.

Colorado's Measles Outbreak Ends as US Cases Continue to Decline

Colorado's measles outbreak has ended, and the US is experiencing a significant decline in weekly cases, with ongoing outbreaks in several states emphasizing the importance of vaccination.

Innovative Blood Pressure Measurement Method Offers Hope for Patients with Limited Arm Access

Researchers have developed a new method for accurately measuring blood pressure at the ankle, aiding those unable to have arm readings and potentially reducing misdiagnoses worldwide.

Semaglutide Usage May Double the Risk of Developing Neovascular Macular Degeneration

Studies reveal that semaglutide, a popular diabetes medication, may double the risk of developing neovascular age-related macular degeneration in older adults, highlighting the need for eye health monitoring during long-term treatment.